Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
191.08
+1.39 (0.73%)
At close: Oct 9, 2025, 4:00 PM EDT
190.75
-0.33 (-0.17%)
Pre-market: Oct 10, 2025, 6:14 AM EDT
Johnson & Johnson Market Cap
Johnson & Johnson has a market cap or net worth of $460.19 billion as of October 10, 2025. Its market cap has increased by 17.44% in one year.
Market Cap
460.19B
Enterprise Value
492.07B
1-Year Change
17.44%
Ranking
Category
Stock Price
$191.08
Market Cap Chart
Since May 14, 2001, Johnson & Johnson's market cap has increased from $136.61B to $460.19B, an increase of 236.86%. That is a compound annual growth rate of 5.10%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 9, 2025 | 460.19B | 32.16% |
Dec 31, 2024 | 348.19B | -7.72% |
Dec 29, 2023 | 377.32B | -18.30% |
Dec 30, 2022 | 461.85B | 2.55% |
Dec 31, 2021 | 450.36B | 8.70% |
Dec 31, 2020 | 414.31B | 7.92% |
Dec 31, 2019 | 383.91B | 10.92% |
Dec 31, 2018 | 346.11B | -7.79% |
Dec 29, 2017 | 375.36B | 19.76% |
Dec 30, 2016 | 313.43B | 10.28% |
Dec 31, 2015 | 284.22B | -2.90% |
Dec 31, 2014 | 292.70B | 13.27% |
Dec 31, 2013 | 258.42B | 33.02% |
Dec 31, 2012 | 194.27B | 8.47% |
Dec 30, 2011 | 179.09B | 5.44% |
Dec 31, 2010 | 169.86B | -4.42% |
Dec 31, 2009 | 177.71B | 7.05% |
Dec 31, 2008 | 166.00B | -13.03% |
Dec 31, 2007 | 190.88B | -0.28% |
Dec 29, 2006 | 191.42B | 7.06% |
Dec 30, 2005 | 178.79B | -5.00% |
Dec 31, 2004 | 188.21B | 22.75% |
Dec 31, 2003 | 153.33B | -3.90% |
Dec 31, 2002 | 159.55B | -11.43% |
Dec 31, 2001 | 180.14B | 31.87% |
View and export this data all the way back to 2001. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 767.88B |
AbbVie | 407.53B |
UnitedHealth Group | 333.01B |
AstraZeneca | 266.87B |
Novo Nordisk | 261.06B |
Novartis AG | 256.06B |
Abbott Laboratories | 232.02B |
Merck & Co. | 218.56B |